SEC Form 4 · accession 0001415889-17-001015
Medovex Corp. · MDVX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jarrett S Gorlin
Officer — CHIEF EXECUTIVE OFFICER · Director
Period of report
Jun 19, 2017
Accepted (ET)
Jun 20, 2017 · 9:00 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001591165
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3,F4 | Jun 19, 2017 | P | 20,000 | $0.90 | A | 662,172 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares purchased trade publicly under the symbol "MDVX" on the NASDAQ Stock Market.
- F2Includes 506,837 shares held by The Jarrett S. & Rebecca L. Gorlin Family Limited Partnership. Mr. Gorlin disclaims beneficial ownership of these shares.
- F3Includes 9,615 shares held by JARRETT GORLIN C/F LOGAN GORLIN UTMA/GA. The Reporting Person claims beneficial ownership of these shares.
- F4Includes 9,615 shares held by JARRETT GORLIN C/F TAYLOR GORLIN UTMA/GA. The Reporting Person claims beneficial ownership of these shares.